These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18219805)

  • 1. ACE, ARB duet questioned.
    Harv Heart Lett; 2007 Dec; 18(4):7. PubMed ID: 18219805
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of ARB and ACE inhibitors in heart failure patients.
    Wexler R; Feldman D
    Am Fam Physician; 2009 Mar; 79(6):454; author reply 456. PubMed ID: 19323357
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy with ACE inhibitors and ARBs in heart failure.
    Cayley WE
    Am Fam Physician; 2004 Jul; 70(2):261. PubMed ID: 15291087
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or both in chronic heart failure.
    Young JB
    Heart Fail Clin; 2005 Apr; 1(1):39-47. PubMed ID: 17386832
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical inquiries. Is combining ACE inhibitors and ARBs helpful or harmful?
    Chavey WE; Nashelsky J; Kilgore D
    J Fam Pract; 2004 Feb; 53(2):138-42. PubMed ID: 14764298
    [No Abstract]   [Full Text] [Related]  

  • 6. Are angiotensin-receptor blockers (ARBs) equivalent to or better than angiotensin-converting enzyme (ACE) inhibitors in the treatment of heart failure?
    Reigle J
    Crit Care Nurse; 2004 Dec; 24(6):67-9. PubMed ID: 15646090
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
    Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
    J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute renal failure during the treatment of heart failure with ACE inhibitors].
    Os I; Fredheim CS; Draganov B; Høieggen A; Andersson KS
    Tidsskr Nor Laegeforen; 2003 Jan; 123(1):30-2. PubMed ID: 12600146
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heart failure. What helps in dyspnea?].
    MMW Fortschr Med; 2002 May; 144(20):63. PubMed ID: 12119890
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiotensin II-receptor blockers].
    Lommi J
    Duodecim; 2005; 121(6):589-92. PubMed ID: 15907084
    [No Abstract]   [Full Text] [Related]  

  • 12. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM; Böhm M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
    Kazi D; Deswal A
    Cardiol Clin; 2008 Feb; 26(1):1-14, v. PubMed ID: 18312901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of ACE inhibitors and ARBs in severe chronic kidney disease: point-counterpoint.
    Creamer LM; Ryan J
    CANNT J; 2008; 18(4):46-8. PubMed ID: 19175194
    [No Abstract]   [Full Text] [Related]  

  • 17. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E
    Am Heart J; 2009 Jun; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: emerging evidence leads to new guidelines.
    Golden WE
    J Ark Med Soc; 2005 Feb; 101(8):248-9. PubMed ID: 15739750
    [No Abstract]   [Full Text] [Related]  

  • 20. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.